|
Basic Characteristics of Mutations
|
|
Mutation Site
|
H275Y+G147R |
|
Mutation Site Sentence
|
These mutant viruses possessed an H275Y/I223R, H275Y/I223K, or H275Y/G147R substitution in their NA and showed enhanced cross-resistance to oseltamivir and peramivir and reduced susceptibility to zanamivir compared to single H275Y mutant viruses. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
NA |
|
Standardized Encoding Gene
|
NA
|
|
Genotype/Subtype
|
H1N1 |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Influenza A
Cell line
|
|
Immune
|
Y |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
oseltamivir;peramivir |
|
Location
|
- |
|
Literature Information
|
|
PMID
|
32887429
|
|
Title
|
In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients
|
|
Author
|
Takashita E,Fujisaki S,Yokoyama M,Shirakura M,Morita H,Nakamura K,Kishida N,Kuwahara T,Sato H,Doi I,Sato Y,Takao S,Shimazu Y,Shimomura T,Ito T,Watanabe S,Odagiri T,The Influenza Virus Surveillance Group Of Japan
|
|
Journal
|
Pathogens (Basel, Switzerland)
|
|
Journal Info
|
2020 Sep 2;9(9):725
|
|
Abstract
|
Influenza A(H1N1)pdm09 viruses carrying a dual neuraminidase (NA) substitution were isolated from immunocompromised patients after administration of one or more NA inhibitors. These mutant viruses possessed an H275Y/I223R, H275Y/I223K, or H275Y/G147R substitution in their NA and showed enhanced cross-resistance to oseltamivir and peramivir and reduced susceptibility to zanamivir compared to single H275Y mutant viruses. Baloxavir could be a treatment option against the multidrug-resistant viruses because these dual H275Y mutant viruses showed susceptibility to this drug. The G147R substitution appears to stabilize the NA structure, with the fitness of the H275Y/G147R mutant virus being similar or somewhat better than that of the wild-type virus. Since the multidrug-resistant viruses may be able to transmit between humans, surveillance of these viruses must continue to improve clinical management and to protect public health.
|
|
Sequence Data
|
-
|
|
|